In a recent Newsweek feature, the Institute for Human Reproduction (IHR) was highlighted as a vanguard in fertility treatment, recognized for its compassionate and individualized approach to helping families overcome reproductive challenges. Based in Illinois and Indiana, IHR is a member of the Pinnacle Fertility Network and has been a prominent figure in reproductive medicine since 2004.
IHR stands out for its tailored approach to fertility care, led by co-medical directors Dr. Ilan Tur-Kaspa and Dr. David Cohen, who bring a wealth of experience and a deep commitment to patient well-being. Alongside them, Drs. Seth Levrant, Mary Wood Molo, and Karissa Hammer contribute to a diverse expertise covering infertility treatments, LGBTQ+ family planning, fertility preservation, and preimplantation genetic testing, ensuring comprehensive care for all patients.
IHR is also renowned for its handling of complex fertility cases, providing a range of services like IUI, IVF, egg freezing, donor options, and gestational surrogacy. IHR's dedication to rapid and accurate diagnostics ensures timely and effective treatment plans for their patients. This commitment to patient-centered care has earned IHR recognition in various esteemed medical listings.
At IHR, our guiding principle is, "Your success is our success," which reflects our deep commitment to achieving successful patient outcomes and supporting all those that need assistance on their fertility journeys. This Newsweek article sheds light on the exceptional work being done at IHR, making it a beacon of hope for many aspiring parents.
Get started on your fertility journey with the compassionate experts at IHR. Schedule an appointment today.